Ambey Laboratories Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Ambey

CMP

76.85

-4.05 (-5.01%)

  • DRHP
₹68

Offer Price

₹ 44.68 Cr

Issue Size

₹ 1,36,000

Min Investment

2,000

Lot size

Time Line

  • 04
    Jul 2024
    Open
  • 08
    Jul 2024
    Close
  • 09
    Jul 2024
    Finalisation of Basis of Allotment
  • 09
    Jul 2024
    Initiation of Refunds
  • 10
    Jul 2024
    Transfer of Shares to Demat Account
  • 11
    Jul 2024
    Listing Date

Objects of the Offer

  • Continue improving financial performance through focus on operational and functional efficiencies.

  • Backward integration for Manufacturing Raw material and forward integration of Finished Goods.

  • Increase in Installed Capacity.

  • Leveraging its market skills, relationship and leadership position in 2, 4 D.

  • Increase wallet share with existing customers and continued focus to expand customer base.

Products & Services

  • Ambey carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides.

Strengths

  • Experienced Management Team.

  • Prime Location of its Manufacturing Facility

  • Quality Assurance and Standards.

  • Cordial Relationships with its Suppliers.

Risks

  • A few of its properties including Registered Office of the Company, are not owned by it. In the event, the company is unable to renew the lease/ rent agreements, or if such agreements are terminated, its may suffer a disruption in the company operations.

  • Rajasthan State Pollution Control Board has directed the company to deposit the amount to the tune of Rs.1,92,02,400 towards environment compensation.

  • Its Board of Directors and Management may change the company operating policies and strategies without prior notice or shareholders` approval.

  • Some of the raw materials that the company use as well as its finished products are hazardous, corrosive and flammable and require expert handling and storage, as applicable. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.

  • Its funding requirements and deployment of the issue proceeds are based on management estimates and have not been independently appraised by any bank or financial institution and actual cost may vary compared with the estimated amount.

Company Promoters

Promoters Holding

Issue For IPO
25.02%
Pre Holding

94.97%

Post Holding

69.95%

Top Promoters Holding

Financials

All values in Cr

Mar-2022 Mar-2023 Mar-2023 3-Yr trend
Revenue 84.60 (3.50%) 104.82 (23.90%) 19.33 (-)
Gross Profit 84.60 (3.50%) 104.82 (23.90%) 19.33 (-)
Net Income 84.60 (3.50%) 104.82 (23.90%) 19.33 (-)
Assets 84.60 (3.50%) 104.82 (23.90%) 19.33 (-)
Liabilities 84.60 (3.50%) 104.82 (23.90%) 19.33 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Ambey Laboratories Ltd 104.82 4.57 38.26 14.62 19.33 0.00 133.17 1.57 0.36
Atul Ltd 5,427.52 514.09 5,767.98 5,767.98 11.00 174.15 1,598.18 8.91 0.01
Meghmani Organics Ltd 2,552.62 237.71 3,198.44 3,198.44 14.24 9.35 65.64 7.43 0.49

Book Running Managers

  • Fast Track Finsec Pvt Ltd

Registrar & Transfer Agent

Link Intime India Pvt Ltd

C-101 247 Park,
L B S Marg,
Vikhroli West - Mumbai-400083
Phone : 91-22-49186000 Fax: 91-22-49186060

Company Contact Information

Ground Flr # 555 Tarla Mohalla,
Ghitorni South West Delhi,
New Delhi - 110030
Phone : 0124 4000 788 Email : cs@ambeylab.com ambeylab.com

Offer Related Information

Initial public offering of up to 65,70,000 equity shares of Rs. 10/- each ("Equity Shares") of Ambey Laboratories Limited ("Ambey" or the "Company") for cash at a price of Rs. 68/- per equity share (the "Issue Price"), aggregating to Rs. 44.68 crores ("The Offer"), comprising a fresh issue of up to 62,58,000 equity shares aggregating to Rs. 42.55 crores by the company ("Fresh Issue") and an offer for sale of up to 3,12,000 equity shares by ("The Promoter Group Selling Shareholders" or "The... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: